Precision Biosciences (DTIL) Other Operating Expenses (2022 - 2026)
Precision Biosciences (DTIL) posted quarterly Other Operating Expenses of $4000.0 for Q1 2026, up 144.44% year-over-year from $1636.4 in Q1 2025, and up 101.03% quarter-over-quarter from -$390000.0 in Q4 2025.
Precision Biosciences (DTIL) Other Operating Expenses (2022 - 2026) Analysis & Trends
Precision Biosciences (DTIL) has reported Other Operating Expenses for 5 consecutive years, with $4000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Operating Expenses rose 144.44% year-over-year to $4000.0; the TTM figure through Mar 2026 stood at -$408000.0 (down 7.37% YoY), while the FY2025 annual figure was -$421000.0, up 3.44% from the prior year.
- Other Operating Expenses climbed to $4000.0 in Q1 2026 per DTIL's latest filing, from -$390000.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $72000.0 in Q2 2023 and bottomed at -$524000.0 in Q4 2023.
- Historically, Other Operating Expenses has averaged -$84000.0 across 5 years, with a median of -$15000.0 in 2022.
- On a YoY basis, Other Operating Expenses climbed as much as 253.19% in 2023 and fell as far as 2657.89% in 2023.
- Precision Biosciences' Other Operating Expenses stood at -$19000.0 in 2022, then slumped by 2657.89% to -$524000.0 in 2023, then jumped by 65.27% to -$182000.0 in 2024, then slumped by 114.29% to -$390000.0 in 2025, then jumped by 101.03% to $4000.0 in 2026.
- Business Quant data shows DTIL's Other Operating Expenses at $4000.0 in Q1 2026, -$390000.0 in Q4 2025, and $3000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Precision Biosciences | 228.31 Mn | 140.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,000.00 |
| Mar 31, 2026 | 4,000.00 |
| Dec 31, 2025 | -390,000.00 |
| Sep 30, 2025 | 3,000.00 |
| Jun 30, 2025 | -25,000.00 |
| Mar 31, 2025 | -9,000.00 |
| Dec 31, 2024 | -182,000.00 |
| Jun 30, 2024 | -189,000.00 |
| Mar 31, 2024 | -65,000.00 |
| Dec 31, 2023 | -524,000.00 |
| Sep 30, 2023 | -2,000.00 |
| Jun 30, 2023 | 72,000.00 |
| Mar 31, 2023 | -7,000.00 |
| Dec 31, 2022 | -19,000.00 |
| Sep 30, 2022 | 47,000.00 |
| Jun 30, 2022 | -47,000.00 |
| Mar 31, 2022 | -11,000.00 |